Skip to main content

TopBuild Promotes John Achille to President and COO

DAYTONA BEACH, Fla., April 02, 2026 (GLOBE NEWSWIRE) — TopBuild Corp. (NYSE:BLD), a leading installer of insulation and commercial roofing and a specialty distributor of insulation and related building products to the construction industry in the United States and Canada, announced that John Achille, Chief Operating Officer, has been promoted to President and Chief Operating Officer effective immediately.As President and COO, Mr. Achille will be responsible for the day-to-day operations of TopBuild’s Installation Services and Specialty Distribution businesses. He will also have responsibility for the Supply Chain organization and all growth initiatives, including Mergers and Acquisitions. Mr. Achille will continue to report to Robert Buck, CEO of TopBuild. “John is a purpose-driven leader who has managed nearly all of our businesses...

Continue reading

Plug Power Selected to Supply a 275 MW GenEco Electrolyzer System for Hy2gen’s Courant Decarbonized Ammonium Nitrate Project in Baie-Comeau, Québec, Canada

Large-scale project award reinforces company’s role as a trusted partner for global industrial decarbonization SLINGERLANDS, N.Y., April 02, 2026 (GLOBE NEWSWIRE) — Plug Power Inc. (NASDAQ: PLUG), a global leader in comprehensive hydrogen solutions, today announced it has been awarded the Front-End Engineering Design (FEED) contract to supply a 275 MW GenEco PEM electrolyzer system for Hy2gen Canada Inc.’s “Courant” project. The system represents one of the largest electrolyzer project awards to Plug to date, underscoring the company’s leadership in delivering superior hydrogen technology on a global scale. Hy2gen is developing the Courant project as one of North America’s largest decarbonized ammonium nitrate facilities, supporting the mining industry’s goals in Québec, Central and Eastern Canada, and beyond. Plug’s scope...

Continue reading

ScottsMiracle-Gro Reaffirms Fiscal 2026 Guidance; Margin Recovery and Growth Plans Remain on Track

MARYSVILLE, Ohio, April 02, 2026 (GLOBE NEWSWIRE) — The Scotts Miracle-Gro Company (NYSE: SMG), the leading marketer of branded consumer lawn and garden products in North America, announced that it is reaffirming its fiscal 2026 guidance as it does not expect the significant global commodity impacts from the Iran War to affect its full-year outlook. The Company noted that approximately 80 percent of its commodities for the fiscal year were locked by the close of its second quarter on March 28, 2026. Additionally, around 90 percent of its cost of goods sold are sourced domestically, including nearly 100 percent of the urea that is a primary input in its fertilizer products. The Company obtains urea from reliable suppliers under previously negotiated contracts. “We are in a very good position when it comes to our cost of goods for...

Continue reading

Liberty Gold Completes Sale of the Gage Project

VANCOUVER, British Columbia, April 02, 2026 (GLOBE NEWSWIRE) — Liberty Gold Corp. (TSX: LGD; OTCQX: LGDTF) (“Liberty Gold” or the “Company”) announces that it has completed the divestiture of the Gage Project (the “Transaction”) to Blue Moon Metals Inc. (“Blue Moon”), for total consideration of approximately US$2 million, via receipt of 420,935 common shares of Blue Moon, plus a 2.0% net smelter return royalty as previously announced in the Liberty Gold news release on March 18, 2026. All shares of Blue Moon received as consideration are subject to a hold period under applicable Canadian securities laws, which will expire four months plus one day from closing of the Transaction. ABOUT LIBERTY GOLD Liberty Gold is a U.S.-focused gold company advancing Black Pine, its 100% owned oxide gold project in Idaho, located within the Great...

Continue reading

Anfield Energy Inc. Submits Notice of Intent for Underground Drilling Program at SM-18 Uranium-Vanadium Project in Colorado, Advancing Fourth Mine in Hub-and-Spoke Strategy

VANCOUVER, British Columbia, April 02, 2026 (GLOBE NEWSWIRE) — Anfield Energy Inc. (TSX.V: AEC; NASDAQ: AEC; FRANKFURT: 0AD) (“Anfield” or the “Company”) is pleased to announce the submission of a Notice of Intent (the “NOI”) to the relevant regulatory authorities in preparation for an underground drilling program at its SM-18 uranium-vanadium project (“SM-18”) in Colorado. The planned underground drilling program is designed to verify and potentially expand existing mineral resources at SM-18. In parallel, the Company will use the drilling campaign as an opportunity to advance the preparation of a comprehensive Plan of Operations, targeted for completion later this year. This work supports the longer-term development of SM-18 as a producing mine. Exhibit: SM-18 historical production and DOE resource estimateDOE lease County DOE...

Continue reading

Abcourt Mines Receives TSXV Approval to Implement a Normal Course Issuer Bid (NCIB)

ROUYN-NORANDA, Quebec, April 02, 2026 (GLOBE NEWSWIRE) — Abcourt Mines Inc. (“Abcourt” or the “Company”) (TSX Venture: ABI) (OTCQB: ABMBF) is pleased to announce that the TSX Venture Exchange (“TSXV”) has approved the Company’s request to implement a normal course issuer bid (“NCIB”) program, through which Abcourt may purchase, for cancellation, up to 80,000,000 of its common shares, representing just under 10% of the public float (811,853,718 common shares on a total of 1,193,348,720 issued and outstanding common shares as of March 30, 2026). The Board of Directors of Abcourt believes that the current market price of the Company’s common shares does not adequately reflect the intrinsic value of the Company, particularly in light of the recent strategic financing with Glencore and the ongoing production ramp-up...

Continue reading

Updated Data from Phase 1b/2 Study of Muzastotug in Combination with KEYTRUDA® (pembrolizumab) in Late-line Patients with Microsatellite Stable Colorectal Cancer Demonstrate Improved Durability of Response

Dose-Dependent Efficacy Results: As of the latest data cut, muzastotug achieved a 31% (8/26) confirmed overall response rate (ORR) in the combined 20 mg/kg dose cohorts, showing a clear improvement over the 13% ORR (5/39) in the combined 10 mg/kg dose cohorts Extended Durability: Median duration of response (mDOR) was not yet reached in the 20 mg/kg cohorts, with responses ongoing beyond 9 months; confirmed mDOR of 6.2 months in the 10 mg/kg cohorts Meaningful Progression-Free Survival (PFS): Median PFS was 6.7 months in the combined 20 mg/kg cohorts, outperforming the 4.8 months observed in the combined 10 mg/kg cohorts Favorable Overall Survival Results: In the 10 mg/kg cohorts (n=41; median follow-up, 23.8 months), median overall survival was 19.8 months, with 48% of patients alive at two years, showing the long-tail survival typical...

Continue reading

Hudbay Announces Repayment of 2026 Senior Unsecured Notes

TORONTO, April 02, 2026 (GLOBE NEWSWIRE) — Hudbay Minerals Inc. (“Hudbay” or the “Company”) (TSX, NYSE: HBM) today announced that it has repaid in full all of its outstanding 4.50% senior unsecured notes due 2026 (the “2026 Notes”), which were originally issued in an aggregate principal amount of $600 million. All amounts are in U.S. dollars, unless otherwise noted. Hudbay repaid the outstanding aggregate principal amount of $472.5 million of 2026 Notes on maturity on April 1, 2026 using a combination of available cash on hand and a $272 million draw on its low-cost revolving credit facilities. The repayment of the 2026 Notes using available liquidity is consistent with Hudbay’s prudent balance sheet management and focus on cost of capital and provides the Company with improved financial flexibility in advance of a Copper World...

Continue reading

Skye Bioscience Treats First Patient in Nimacimab Higher-Dose Expansion Study Evaluating Exposure-Response to Inform Phase 2b Dose Selection for GLP-1 Combination Development

Topline safety and pharmacokinetic data expected in Q4 2026; an independent Data Monitoring Committee is overseeing the study SAN DIEGO, April 02, 2026 (GLOBE NEWSWIRE) — Skye Bioscience, Inc. (Nasdaq: SKYE) (“Skye”) a clinical-stage biotechnology company focused on unlocking new therapeutic pathways for obesity and other metabolic health disorders, has treated the first patient in its Part C expansion study of the CBeyond Phase 2a trial to characterize safety and pharmacokinetics (PK) at exposures designed to challenge the peripheral restriction of nimacimab through intravenous (IV) administration over 16 weeks of treatment. These doses will set the benchmark for the safety profile of nimacimab and support higher dosing in combination with incretin therapies. The expansion study comprises two cohorts of nimacimab monotherapy (400...

Continue reading

Aurora Mobile Unveils 500% Efficiency Boost Case Study at Tourism × Web3 Summit 2026

SINGAPORE, April 02, 2026 (GLOBE NEWSWIRE) — Aurora Mobile Limited (NASDAQ: JG) (“Aurora Mobile” or the “Company”), a leading provider of customer engagement and marketing technology services, is pleased to announce that its Japanese subsidiary, Aurora Mobile Japan K.K., successfully participated as a sponsor and keynote speaker at the “Tourism × Web3 Summit 2026.” The event served as a premier stage for the Company to demonstrate how its AI-driven capabilities are revolutionizing the tourism and Web3 sectors. Keynote Highlights: Redefining Engagement with an AI-First ApproachAkio Mitobe, CTO of Aurora Mobile Japan K.K., delivered a special pitch on the transformative impact of EngageLab, the Company’s AI-first customer engagement platform. He introduced a “Full-Journey AI Engagement Ecosystem” that seamlessly...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.